A citation-based method for searching scientific literature

F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel, Wallace Akerley, Alfons J M van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia M Vaubel, Gerald P Linette, David Hogg, Christian H Ottensmeier, Celeste LebbĂ©, Christian Peschel, Ian Quirt, Joseph I Clark, Jedd D Wolchok, Jeffrey S Weber, Jason Tian, Michael J Yellin, Geoffrey M Nichol, Axel Hoos, Walter J Urba. N Engl J Med 2010
Times Cited: 9840



Frank Stephen Hodi, Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Charles Lance Cowey, Christopher D Lao, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier Francesco Ferrucci, Michael Smylie, Andrew Hill, David Hogg, Ivan Marquez-Rodas, Joel Jiang, Jasmine Rizzo, James Larkin, Jedd D Wolchok. Lancet Oncol 2018
Times Cited: 664




List of shared articles



Times cited


Immune checkpoint inhibitors for the treatment of melanoma.
Francesco Sabbatino, Luigi Liguori, Stefano Pepe, Soldano Ferrone. Expert Opin Biol Ther 2022
0

Incidence of hepatotoxicity associated with addition of immune checkpoint blockade to systemic solid tumor therapy: a meta-analysis of phase 3 randomized controlled trials.
Yu Fujiwara, Nobuyuki Horita, Matthew Harrington, Ho Namkoong, Hirotaka Miyashita, Matthew D Galsky. Cancer Immunol Immunother 2022
0

Adjuvant and Neoadjuvant Therapies in Cutaneous Melanoma.
Jay Ponto, R Bryan Bell. Oral Maxillofac Surg Clin North Am 2022
0

Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAFV600 mutation-positive melanoma.
C Robert, K D Lewis, R Gutzmer, D Stroyakovskiy, H Gogas, S Protsenko, R P Pereira, T Eigentler, P Rutkowski, L Demidov,[...]. Ann Oncol 2022
0

Current Clinical Trial Landscape of OX40 Agonists.
Rashi Yadav, William L Redmond. Curr Oncol Rep 2022
1